2. Replacement of the Chronic Fatigue Service
2.1 Background and Current Position
Having given the CCG notice to terminate delivering the service, on 31st March 2018 ELFT will cease to operate its Chronic Fatigue Service for ELC CCG’s (Newham, Tower Hamlets and City & Hackney). As of December 2017, ELFT is no longer accepting referrals for City and Hackney Patients and the CCG will be spot purchasing from its Non-Costed Activity Budget.
The new service model will replace the tri-borough model with a City and Hackney only service. It will also combine chronic pain and chronic fatigue within a Complex Chronic Condition Services.
Recommended treatments for chronic fatigue and chronic pain share important similarities such as the use of physiotherapy, psychology and occupational therapy with required medical input. The new combined service will therefore allow expertise to be shared between chronic pain and chronic fatigue. It is also essential that the service is commissioned locally as this patient group find it hard to travel. Combining fatigue and pain services will also lead to economies of scale meaning the service offers better value for money than if it was procured.
The Homerton University Hospital are the only local provider of a chronic pain service and are a provider that is fully integrated into the Hackney and City integrated commissioning arrangements. As a provider they also have locally accessible clinical space that can be used to deliver the services.
2.2 Key issues
Spot purchasing is 82% more expensive compared to a locally commissioned services. City and Hackney receive approximately 70 patients per year for Chronic Fatigue Assessment and Treatment. The average cost of a full treatment from a spot purchase arrangement is £4,258 compared to an estimated cost of £2,327 for a locally commissioned service. Although it is possible a local service could lead to a higher volume of demand, nevertheless it seems likely that a local service would be less costly than spot purchase arrangement. Service level agreements are only marginally less expensive. Furthermore, Chronic Fatigue patients tend to find travelling problematic particularly in the initial phases of treatment and hence there are strong advantages to providing a local service. Therefore providing a replacement service will be significantly less expensive than the alternative of spot purchasing arrangement and better for patients. Economies of scale can be realised by aligning the new service to HUH’s pain clinic.
2.3 Service Objectives
- To provide an equitable specialist CFS/ME service across City and Hackney
- To provide specialist input based on need in proportion to the population profile
- To implement NICE guidance
- To improve Health and wellbeing promoting social inclusion and improving economic productivity
- To ensure, that appropriate targets are met
- To ensure people with CFS/ME have improved health and wellbeing outcomes including social inclusion, and access to mainstream health and social care systems
- To ensure sufficient capacity, utilised productively to:
- Provide timely response
- Promote Patient Choice
- Avoid Waiting lists
- Provide specialist therapy skills where required
2.4. Service Model
2.4.1 Provider: The replacement service will managed by Homerton University Hospital NHS Foundation Trust
2.4.2 Location: Chronic Fatigue Service, 'A' Block, St Leonard's, Nuttall Street, London, N1 5LZ
2.4.3 Days / hours of operation
Monday – Friday 9am-5pm
2.4.4 Referral processes
GP or other medical practitioner (Medical test conducted and included in referrals)
The therapies and treatments offered are consistent with the NICE guidelines
(
http://guidance.nice.org.uk/)
2.4.5 The Model of Care
The NICE (2007) guidelines describe a specialist CFS/ME service as:
‘A service providing expertise in assessing, diagnosing and advising on the Clinical management of CFS/ME, including symptom control and specific interventions. Ideally this is provided by a multidisciplinary team, which will have appropriate access to clinicians with a special interest in the condition’
The service will offer a stepped approach dependent on need and based on the levels of severity as defined in the NICE guidance. Providing a person-centred programme that aims to:
- Sustain or extend the physical, emotional and cognitive capacity based on their needs, the type, duration, complexity and severity of their symptoms and the presence of co-morbidities
- Manage and treat the physical and emotional impact of symptoms and their underlying cause.
- Signpost to appropriate local support networks, health, social care, employment and voluntary organisations dependent on need.
- Facilitate effective management which includes engagement with family and carers
- Meet the identified needs of adults (18+) in the City & Hackney and be equitable across this area.
- Liaise with children’s services regarding transitions to adult services and the development of children’s services
3.3.6 The Care Pathway
The care pathway is shown in the diagram below. As can be seen the first stage of the diagnostics involving bloods and a general assessment is conducted by the GP. This avoids unnecessary referrals into secondary care and keeps the first stage accessible and close to the patient’s home. If there is diagnostic uncertainty the GP can refer to a secondary care. If there is physical health diagnostic uncertainty this might be to HUH rheumatology or general medicine. On the mental health side this might be to psychiatry within ELFT’s Primary Care Liaison Service or CHAMRAS assessment service.
If there are clear diagnostic indicators for Chronic Fatigue a referral is made to the Complex Chronic Condition Service where a further assessment will be done. Again if there is diagnostic uncertainty a referral to psychiatry, general medicine or rheumatology will be made. Once the diagnosis is clear the service will complete NICE recommended chronic fatigue treatments.
Figure 1: Chronic Fatigue Care Pathway (refer to source PDF for flowchart)
Supporting Papers and Evidence:
NICE 22 Aug 2007: Chronic Fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management.
Sign-off:
[Papers for approval by the ICBs must be signed off by the appropriate senior officers. Any paper with financial implications must be signed by the Members of the Finance Economy Group.
If there are any legal implications which require consultation with legal counsel, please make reference to that below.
Copies of email sign-off should be sent to the Secretariat (
matthewhopkinson@nhs.net) along with the papers. Papers which have not been
signed-off by the appropriate officers will not be considered by the Committee.]
Workstream SRO - This paper has been approved by the Mental Health Co-ordinating Committee, which includes the Workstream Directors. It has also been approved by the CCG Finance and Performance Committee and the CCG Clinical Executive. The following people have been cited and had an opportunity to input into the proposals.
Planned Care Workstream Director: Siobhan Harper
Unplanned Care Workstream Director: Nina Griffith
Prevention Workstream Director Gareth Wall
City and Hackney CCG: Dr Mark Ricketts, Chair, City and Hackney CCG
City and Hackney CCG: David Maher, Acting Managing Director
City and Hackney CCG: Dr Rhiannon England, Mental Health Clinical Lead
East London NHS Foundation Trust: Dr David Bridle, City & Hackney Clinical Director
London Borough of Hackney: Nicole Klynman,
London Borough of Hackney: Lesley Hill, Strategic Commissioning Lead for MH, Homelessness, Advocacy
City of London Corporation: Chris Pelham, Assistant Director of People, Department of Community and Children’s Services
City of London Corporation: Mark Davidson, Senior Commissioning Manager